Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Hanseníase: olhar epidemiológico nas regiões brasileiras nos últimos anos

Sousa LS, Vieira SMM, Rabelo ECS, et al. Brazilian Journal of Implantology and Health Sciences. Brazilian Journal of Implantology and Health Sciences. 2024; 6 (4) : 647-656.
Download PDF
Publication

Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction

Rosa TLSA, Leal-Calvo T, Tavares IF, et al. Frontiers Media SA. Frontiers in Immunology. 2024;
Download PDF
Publication

Zero Leprosy Strategic Plans: Global and National Level: A Short Communication

Geetha K. Medknow. Clinical Dermatology Review. 2024; 8 (2) : 167-170.
Download PDF
Publication

Leprosy in Brazil: From the social developments to the diagnosis-therapeutic evolution of the disease

Costa AKM, Silva DCSE, Rosa PHDR, et al. Seven Editora. Eyes on Health Sciences V.02. 2024;
Download PDF
Publication

Scoping Review: Effectiveness of NDO-LID as new biomarker for leprosy diagnosis

Julianto R, Putri R. D.. Intisari Sains Medis. 2024; 15 (1) : 331-335.
Download PDF
Publication

Lepra: una enfermedad de la piel olvidada

Solana A. D. C, Navarrete M. R. Dermatología Revista Mexicana. 2024; 68 (2) : 151-152.
Download PDF
Publication

Datos epidemiológicos de la casuística de lepra en un hospital de tercer nivel de 1990 a 2023

Ruiz K. U. R, Vincent N. A. M, Arenas R, et al. Dermatología Revista Mexicana. 2024; 68 (2) : 170-180.
Download PDF
Publication

Lepra lepromatosa en un receptor de trasplante cardiaco: un reto clínico y terapéutico

López R. F. R, Hurtado D. I. C, Molinares L. I. L. Dermatología Revista Mexicana. 2024; 68 (2) : 279-281.
Download PDF
Publication

Erythema Nodosum Leprosum Reaction Masquerading as Rheumatoid Arthritis

Deo K, Reddy A, Manoj R, et al. Springer Science and Business Media LLC. Cureus. 2024; 16 (3) : 1-4.
Download PDF
Publication

Hansen’s Disease: A Practical Update on a Neglected Globally Significant Infection

Benlamkadam S, Errahmany A, Raymond K, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 93
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD